GIGA-D-17-00033This is a timely and well-written article that summarises current or emerging standards for reporting metagenomic projects. A need to harmonise reporting of metagenomic project is certainly given and the manuscript covers all relevant aspects with depth of knowledge. While the main objective of this manuscript is to describe standards for reporting data, it would be also worthwhile mentioning the need (and associated standards) to store and report on the actual biological samples or extracted nucleic acids. These represent very valuable resources both in terms of sampling effort and the fact that they are often unique in time and space. Furthermore those resources could be re-analysed in the future with new sequencing technologies providing additional opportunities to enhance database content. In addition, I have the following comment to consider for improving the manuscript:Page 6; Line 54: I think it is important to note that primary data might require additional meta-information. While I appreciate that primary datasets can sometimes already include some basic analysis, information on the type of analysis should be attached to the primary datasets. As primary datasets are sometimes directly compared (e.g. in terms of size or quality) and a lack of information about potential processing would likely lead to bias.Page 12; Line 42: DNA extraction is certainly one step in metagenomics projects, where a large range of protocols exists that would require much detailed information to be captured. However such information can be stored in external databases that specialise in standardising and sharing protocols, such as protocols.io. In fact protocol.io can captured and display variations in protocols, which would facilitate the comparison of studies, and perhaps, in the long run bring users towards using more common extraction methods. I would suggest that the authors consider this as an additional requirement or extension of the desired reporting structure.Page 15, Line 23: Please provide references for EMG and MG-RAST.
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